Clinical trials
Cancer Patients clinical trials
Below are recruiting cancer patients clinical trials, each written for real people, not researchers. We’re tracking 3,622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06046794Recruiting
Gemcitabine for metastatic pancreatic cancer patients
This trial tests gemcitabine chemotherapy in people with metastatic pancreatic cancer who cannot take FOLFIRINOX. It aims to see how well gemcitabine works based on a specific tumor marker called GemCore.
MarseilleAges 18 years+ - NCT06070870Recruiting
Lung screening help for Black adults
This trial helps Black or African-American adults who smoke or quit recently learn about and get lung cancer screening. It uses a health education approach to guide you through the process.
Carrboro, North CarolinaAges 50–80 - NCT06106360Recruiting
Using an Apple Watch and iPhone to monitor chemo patients at home
This study tests whether using an Apple Watch and a health app on your iPhone can help monitor how you're doing during chemotherapy. Doctors want to see if tracking your health at home can catch problems early and keep you safer.
Fairfax, VirginiaAges 18 years+ - NCT06136845Recruiting
Esophageal cancer microbiome and leak after surgery
This study looks at bacteria in esophageal cancer tumors and whether certain bacteria are linked to leaks that can happen after surgery to remove the esophagus. It may help doctors understand how to prevent these leaks in the future.
HaifaAges 18–85 - NCT06185777Recruiting
Exercise therapy program for cancer patients in treatment
This study is testing a care program that helps cancer patients add exercise to their treatment. If you're currently on chemo, immunotherapy, or radiation and have side effects like fatigue (or just want guidance on exercise), you may be able to join.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT06195709RecruitingPhase 3
Study of PET imaging and blood tests for ER+ HER2- metastatic breast cancer
This trial tests a new imaging technique (18F-FES PET/CT) along with blood markers to guide treatment for metastatic breast cancer that is ER-positive and HER2-negative. It's for people whose cancer progressed on first-line hormone therapy and who are starting a second line of hormone therapy.
BayonneAges 18 years+ - NCT06209853Recruiting
PSA levels and PSMA PET/CT in prostate cancer
This study looks at how PSA levels (a blood test marker for prostate cancer) relate to images from a special scan called F-18 PSMA PET/CT. It helps doctors understand what the scan results mean for your cancer.
AsyutAges Any age - NCT06248996RecruitingPhase 3
Testing a stronger radiation schedule for large head and neck cancers
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
GävleAges 18–100 - NCT06262139RecruitingPhase 1/Phase 2
New MRI dye for high-risk prostate cancer
This trial tests a new MRI contrast dye that might help doctors see aggressive prostate cancer more clearly. It is for men with high-risk prostate cancer (Gleason 8-10) who have already had an MRI and a biopsy.
Atlanta, GeorgiaAges 18–90 - NCT06310902Recruiting
Single-cell study for resectable pancreatic cancer patients
This trial uses a special technique called single-cell sequencing to study pancreatic cancer cells from patients whose tumors can be surgically removed or are on the edge of being removable. Participation may help researchers understand the disease better and could guide future treatments.
Fuzhou, FujianAges 18–75 - NCT06315010RecruitingPhase 2
Repotrectinib for ROS1-positive lung cancer with brain spread
This clinical trial tests a new targeted therapy pill (repotrectinib) for people with ROS1-positive lung cancer that has spread to the brain. The pill is designed to enter the brain and attack cancer cells that other targeted treatments may not reach well.
GrazAges 18 years+ - NCT06354712RecruitingPhase 2
Can N-acetylcysteine prevent mouth sores during radiation?
This study tests whether a medicine called N-acetylcysteine (NAC) can prevent mouth sores caused by radiation therapy for head and neck cancer. If you are starting radiation, this trial may help protect your mouth from painful side effects.
Al MansurahAges 18–80 - NCT06379113RecruitingPhase 2/Phase 3
Hormone therapy for obesity-linked endometrial cancer that didn't respond to progestin
This trial tests a combination of two hormone-blocking drugs (GnRHa plus letrozole) for women with early-stage, obesity-related endometrial cancer who haven't responded well to standard hormone therapy alone. The goal is to preserve the uterus and fertility while controlling the cancer.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT06418204Recruiting
Cannabis use study for cancer patients in community clinics
This study looks at the benefits and risks of using cannabis or cannabinoids for cancer patients. It aims to help understand how these products affect symptoms and quality of life during chemotherapy or immunotherapy.
Fairbanks, AlaskaAges 18 years+ - NCT06421285Recruiting
Exercise before breast cancer surgery to prevent lymphedema
This trial tests whether doing exercise before surgery can help prevent arm swelling (lymphedema) in women being treated for breast cancer. If you are newly diagnosed, facing chemotherapy first, and can exercise safely, this study might be a good fit.
Seoul, Seoul Special CityAges 20–80 - NCT06505057Recruiting
Freezing and re-implanting ovarian tissue for young cancer patients
This study tests a method to preserve fertility by freezing ovarian tissue before cancer treatment and later re-implanting it. It may help young women and girls who face infertility from their cancer therapy.
Hong KongAges 12–18 - NCT06512662Recruiting
Support program for ENT cancer patients in a day hospital
This trial offers a support program for patients undergoing surgery for head and neck cancer. The goal is to help with recovery and well-being.
BrestAges 18 years+ - NCT06518434RecruitingPhase 2
Cannabis oil for advanced liver cancer study
This study tests if cannabis oil can help people with advanced liver cancer that cannot be treated with standard therapies. It is a small pilot study to see if the oil is safe and may improve symptoms or quality of life.
GroningenAges 18 years+ - NCT06525181Recruiting
AI Symptom Tracking for Pelvic Radiation Therapy
This trial uses an AI tool to help track your weekly symptoms during pelvic radiation therapy. It aims to make it easier for you and your care team to monitor and manage side effects.
Rio de JaneiroAges 18 years+ - NCT06532773RecruitingDurham, North CarolinaAges 18 years+
- NCT06589544Recruiting
Virtual reality and brain stimulation for depression in cancer patients
This trial tests whether combining virtual reality therapy with transcranial magnetic stimulation (a non-invasive brain treatment) can help reduce depression in people who have had cancer in the last 5 years. It aims to improve mood without using medication.
Ferrara, FEAges 18–100 - NCT06686979Recruiting
Drug sensitivity test for advanced salivary gland cancer
This trial tests whether a laboratory-grown mini-tumor (organoid) from your biopsy can predict which drugs will work best for your recurrent or metastatic salivary gland cancer. You would need to provide a tumor sample and have adequate organ function.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06761144Recruiting
Detecting blood clots in lungs of cancer patients in the ER
This trial studies how to quickly and safely rule out blood clots in the lungs of cancer patients who come to the emergency room. It aims to help doctors make faster decisions and avoid unnecessary treatments for people with cancer.
BolognaAges 18 years+ - NCT06770452RecruitingPhase 2
HRS-4642 combo for first-line advanced pancreatic cancer
This trial tests a new targeted drug (HRS-4642) combined with nimotuzumab and chemotherapy for people with advanced pancreatic cancer that has a specific gene change called KRAS G12D. It's for those who haven't had treatment for advanced disease yet.
Hangzhou, ZhejiangAges 18–75
Hear when a new Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer patients?
- Yes. Clin2 currently lists 3,622 recruiting cancer patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.